Cases & Deals

Abiomed invests in Protembis

Clients Abiomed, Inc.

Jones Day advised Abiomed, Inc., a U.S. listed medtech company, in connection with its purchase of Series A Preferred Stock in a private placement by Protembis GmbH, a medical device start-up company based in Aachen, Germany.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.